Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2019, Article ID 4567106, 6 pages
https://doi.org/10.1155/2019/4567106
Research Article

Differential Expression of Inflammation-Related Genes in Down Syndrome Patients with or without Periodontal Disease

1Oral Surgery Department, Dentistry Faculty, University of Seville, Seville, Spain
2Instituto de Biomedicina de Sevilla, Seville, Spain
3Dentistry in Handicapped Patients Department, Dentistry Faculty, University of Seville, Seville, Spain
4Dentistry in Handicapped Patients Department, Quirón Hospital, San Sebastián, Spain
5Oral and Maxillofacial Unit, Virgen del Rocio Hospital, Seville, Spain

Correspondence should be addressed to J. L. Gutiérrez-Pérez; se.su@pglj and M. A. Serrera-Figallo; se.su@arerresam

Received 26 June 2019; Accepted 6 September 2019; Published 21 October 2019

Academic Editor: Settimio Rossi

Copyright © 2019 M. Baus-Domínguez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. F. Kinane, “Periodontitis Modified by Systemic Factors,” Annals of Periodontology, vol. 4, pp. 54–63, 1999. View at Publisher · View at Google Scholar
  2. N. Ahmed, H. Parthasarathy, M. Arshad, D. J. Victor, D. Mathew, and S. Sankari, “Assessment of Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans in Down’s syndrome subjects and systemically healthy subjects: A comparative clinical trial,” Journal of Indian Society of Periodontology, vol. 18, pp. 728–733, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Khocht, T. Yaskell, M. Janal et al., “Subgingival microbiota in adult Down syndrome periodontitis,” Journal of Periodontal Research, vol. 47, pp. 500–507, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. J. M. Albandar, “Aggressive and acute periodontal diseases,” Periodontology 2000, vol. 65, pp. 7–12, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Slots and A. Contreras, “Herpesviruses: a unifying causative factor in periodontitis?” Oral Microbiology and Immunology, vol. 15, pp. 277–280, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Kulkarni and D. F. Kinane, “Host response in aggressive periodontitis,” Periodontology 2000, vol. 65, pp. 79–91, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Kohcht, B. Russell, J. G. Cannon, B. Turner, and M. Janal, “Oxidative burst intensity of peripheral phagocytic cells and periodontitis in Down syndrome,” Journal of Periodontal Research, vol. 49, pp. 29–35, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Subramaniam, K. L. Girish-Babu, and L. Mohan-Das, “Assessment of salivary total antioxidant levels and oral health status in children with Down syndrome,” Special Care in Dentistry, vol. 34, pp. 193–200, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Komatsu, Y. Duckyoung, A. Ito et al., “Increased oxidative stress biomarkers in the saliva of Down syndrome patients,” Archives of Oral Biology, vol. 58, pp. 1246–1250, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Iwamaoto, A. Yamada, K. Yuasa et al., “Influences of interferon-gamma on cell proliferation and interleukin-6 production in Down syndrome derived fibroblasts,” Archives of Oral Biology, vol. 54, pp. 963–969, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. M. H. Tanaka, E. M. A. Giro, L. B. Cavalcante et al., “Expression of interferon-γ, interferon-α and related genes in individuals with Down syndrome and periodontitis,” Cytokine, vol. 60, pp. 875–881, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. L. B. Cavalcante, M. H. Tanaka, J. R. Pires et al., “Expression of the interleukin-10 signaling pathway genes in individuals with Down syndrome and periodontitis,” Journal of Periodontology, vol. 83, pp. 926–935, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Tsilingardis, T. Yucel-Lindberg, and T. Modéer, “Altered relationship between MMP-8 and TIMP-2 in gingival crevicular fluid in adolescents with Down’s syndrome,” Journal of Periodontal Research, vol. 48, pp. 553–562, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. C. R. Silva, J. M. Biselli-Périco, B. L. Zampieri et al., “Differential expression of inflammation-related genes in children with Down syndrome,” Mediators of Inflammation, vol. 2016, 8 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. Online Mendelian Inheritance in Man - OMIM®, “Tumor necrosis factor ligand superfamily, member 13B; TNFSF13B (B-lymphocyte stimulator, B cell-activating factor, TNF- and apolitically-related leukocyte expressed ligand 1, TALL1) [Homo sapiens (human)],” 2009, https://www.omim.org/entry/603969?search=TNFSF13B&highlight=tnfsf13b.
  16. D. G. Bassani, M. T. A. Olinto, and N. Kreiger, “Periodontal disease and perinatal outcomes: a case-control study,” Journal of Clinical Periodontology, vol. 34, pp. 31–39, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. F. B. Vincent, R. Kandane-Rathnayake, A. Y. Hoi et al., “Urinary B-cell-activating factor of the tumour necrosis factor family (BAFF) in systemic lupus erythematosus,” Lupus, vol. 27, pp. 2029–2040, 2018. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Thompson, D. A. Isenberg, E. C. Jury, and C. Ciurtin, “Exploring BAFF: its expression, receptors and contribution to the immunopathogenesis of Sjögren’s syndrome,” Rheumatology, vol. 55, no. 9, pp. 1548–1555, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Wei, Y. Chang, and W. Wei, “The role of BAFF in the progression of rheumatoid arthritis,” Cytokine, vol. 76, pp. 537–544, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. Kyoto Encyclopedia of Genes and Genomes; diagrams of signaling pathways, “Cytokine-cytokine receptor interaction [Homo sapiens (human)],” 2018 https://www.genome.jp/dbget-bin/www_bget?hsa04060.
  21. G. Ferraccioli and E. Gremese, “B cell activating factor (BAFF) and BAFF receptors: fakes and facts,” Clinical and Experimental Immunology, vol. 190, pp. 291-292, 2017. View at Publisher · View at Google Scholar · View at Scopus
  22. Kyoto Encyclopedia of Genes and Genomes; diagrams of signaling pathways, “NF-kappa B signaling pathway [Homo sapiens (human)],” 2019 https://www.genome.jp/dbget-bin/www_bget?hsa04064.
  23. Online Mendelian Inheritance in Man - OMIM®, “Integrin beta-2 (leukocyte cell adhesion molecule CD18, CD18) [Homo sapiens (human)],” 2009 https://www.omim.org/entry/600065?search=ITGB2&highlight=itgb2.
  24. G. M. Taylor, A. Williams, S. W. D. Souza et al., “The expression of CD18 is increased on trisomy 21 (Down syndrome) lymphoblastoid cells,” Clinical & Experimental Immunology, vol. 71, pp. 324–328, 1988. View at Google Scholar
  25. Kyoto Encyclopedia of Genes and Genomes; diagrams of signaling pathways, “Leukocyte adhesion deficiency [Homo sapiens (human)],” 2017 https://www.genome.jp/dbget-bin/www_bget?ds:H00099.
  26. A. Justiz Vaillant Angel and F. Ahmad, Leukocyte Adhesion Deficiency, StatPearls Publishing, 2019.
  27. Online Mendelian Inheritance in Man - OMIM®, “Annexin A3 (Annexin III, ANX3, Lipocortin III) [Homo sapiens (human)],” 2009 https://www.omim.org/entry/106490?search=ANXA3&highlight=anxa3.
  28. The National Center for Biotechnology Information – NCBI, “ANXA5 (Annexin A5) [Homo sapiens (human)],” 2009 https://www.ncbi.nlm.nih.gov/gene/308.
  29. S. E. Moss and R. O. Morgan, “The annexins,” Genome Biology, vol. 5, no. 4, p. 219, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Wu, S. Liu, C. Guo, Z. Hou, and M. Z. Sun, “The role of annexin A3 playing in cancers,” Clinical and Translational Oncology, vol. 15, no. 2, pp. 106–110, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. M. J. Hayes and S. E. Moss, “Annexins and disease,” Biochemical and Biophysical Research Communications, vol. 322, no. 4, pp. 1166–1170, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Luo, X. Ji, J. Fan et al., “Annexin A5 promotes macrophage activation and contributes to pulmonary fibrosis induced by silica particles,” Toxicology and Industrial Health, vol. 32, no. 9, pp. 1628–1638, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. J. H. Rand, X.-X. Wu, E. Y. Lin, A. Griffel, P. Gialanella, and J. C. McKitrick, “Annexin A5 binds to lipopolysaccharide and reduces its endotoxin activity,” MBio, vol. 3, no. 2, pp. 1–6, 2012. View at Publisher · View at Google Scholar · View at Scopus